Danny's inspiring survival story
30 May 2020
Danny Strosberg started to feel something was wrong when he noticed constant dizziness, daily headaches, and started to lose his vocabulary.
That’s when a CT scan revealed an egg-sized melanoma in his brain.
Danny underwent surgery to remove the tumour followed by six months of treatment. After a number of other tumours appeared throughout his body, he was placed on an immunotherapy clinical trial. It proved to be life saving.
Thanks to generous supporters, melanoma research has come so far. But we still have a long way to go. Our focus remains on achieving zero deaths from melanoma - a goal we believe we can reach in our lifetime.
“I had a complete response within about six months. All of my tumours disappeared.” Danny
Danny proudly calls himself a melanoma survivor. More than ever, he appreciates life, his friends and loved ones. He loves surfing and spending precious time with his wife Lisa and teenage daughter Gabby.
For patients like Danny, whose melanoma has spread to organs like their brain or lungs, clinical trials of new treatments are giving them a second chance at life.
Any life lost to melanoma is one too many. With your support, we will continue our research effort until we achieve our mission of zero deaths from melanoma.
Danny appreciates how immunotherapy treatment saved his life. Now he wants to give other patients the hope to watch their families grow up.
“The advances in melanoma research are being translated to other cancers, and the potential benefits are limitless. I literally owe my life to the work that is being done at MIA.” Danny
We hope Danny’s story inspires you to consider sending a donation.
Your gift could help fund a game-changing new treatment so that – one day very soon – no-one will die from melanoma.
Click below to donate securely via credit card, PayPal or direct deposit. Gifts over $2 are tax-deductible.
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.
Ben Garrow lost his life to melanoma. In his honour his family has established a scholarship to support a PhD student whose work focuses on saving lives from melanoma.
More than 150 clinicians, researchers and MIA staff gathered online to share research highlights.
Independent researchers at The University of Sydney are seeking patient feedback.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Postponed to early 2022. Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.
The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.